Literature DB >> 33713249

Atypical Presentation of Severe Fungal Necrotizing Fasciitis in a Patient with X-Linked Agammaglobulinemia.

Chai Teng Chear1, Revathy Nallusamy2, Kwai Cheng Chan2, Ratna Mohd Tap3, Mohd Farid Baharin1, Sharifah Nurul Husna Syed Yahya1, Prasobhan Bala Krishnan1, Saharuddin Bin Mohamad4,5, Adiratna Mat Ripen6.   

Abstract

X-linked agammaglobulinemia is a rare primary immunodeficiency due to a BTK mutation. The patients are characteristically deficient in peripheral B cells and serum immunoglobulins. While they are susceptible to infections caused by bacteria, enteroviruses, and parasites, fungal infections are uncommon in XLA patients. Here, we report a boy of Malay ethnicity who suffered from recurrent upper respiratory tract infections and severe progressive necrotizing fasciitis caused by Saksenaea erythrospora. Immunological tests showed a B cell deficiency and hypogammaglobulinemia. Whole-exome sequencing identified a dinucleotide deletion (c.1580_1581del) in BTK, confirmed by Sanger sequencing and predicted to be disease causing by in silico functional prediction tools (Varsome and MutationTaster2) but was absent in the gnomAD database. This mutation resulted in a frameshift and premature termination (p.C527fs), which disrupted the protein structure. The mother was heterozygous at the mutation site, confirming her carrier status. Flow cytometric analysis of monocyte BTK expression showed it to be absent in the patient and bimodal in the mother. This study describes a novel BTK mutation in a defined hotspot and an atypical fungal phenotype in XLA. Further studies are required to understand the pathogenesis of fungal infection in XLA.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  BTK; Necrotizing fasciitis; Saksenaea erythrospora; X-linked agammaglobulinemia; mutation

Mesh:

Substances:

Year:  2021        PMID: 33713249     DOI: 10.1007/s10875-021-01017-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  42 in total

1.  Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality.

Authors:  Vassilios Lougaris; Annarosa Soresina; Manuela Baronio; Davide Montin; Silvana Martino; Sara Signa; Stefano Volpi; Marco Zecca; Maddalena Marinoni; Lucia Augusta Baselli; Rosa Maria Dellepiane; Maria Carrabba; Giovanna Fabio; Maria Caterina Putti; Francesco Cinetto; Claudio Lunardi; Luisa Gazzurelli; Alessio Benvenuto; Patrizia Bertolini; Francesca Conti; Rita Consolini; Silvia Ricci; Chiara Azzari; Lucia Leonardi; Marzia Duse; Federica Pulvirenti; Cinzia Milito; Isabella Quinti; Caterina Cancrini; Andrea Finocchi; Viviana Moschese; Emilia Cirillo; Ludovica Crescenzi; Giuseppe Spadaro; Carolina Marasco; Angelo Vacca; Fabio Cardinale; Baldassare Martire; Antonino Trizzino; Maria Licciardello; Fausto Cossu; Gigliola Di Matteo; Raffaele Badolato; Simona Ferrari; Silvia Giliani; Andrea Pession; Alberto Ugazio; Claudio Pignata; Alessandro Plebani
Journal:  J Allergy Clin Immunol       Date:  2020-03-10       Impact factor: 10.793

2.  Susceptibility to fungal infections of nails in patients with primary antibody deficiency.

Authors:  Anna B Macura; Anna Macura-Biegun; Bolesław Pawlik
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2003-07       Impact factor: 2.268

3.  Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females.

Authors:  T Futatani; C Watanabe; Y Baba; S Tsukada; H D Ochs
Journal:  Br J Haematol       Date:  2001-07       Impact factor: 6.998

4.  X-linked agammaglobulinemia complicated with pulmonary aspergillosis.

Authors:  Kentaro Nishi; Toshinao Kawai; Mitsuru Kubota; Akira Ishiguro; Masafumi Onodera
Journal:  Pediatr Int       Date:  2018-01       Impact factor: 1.524

Review 5.  Defects in early B-cell development: comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse.

Authors:  M E Conley; J Rohrer; L Rapalus; E C Boylin; Y Minegishi
Journal:  Immunol Rev       Date:  2000-12       Impact factor: 12.988

6.  X-linked agammaglobulinemia: report on a United States registry of 201 patients.

Authors:  Jerry A Winkelstein; Mary C Marino; Howard M Lederman; Stacie M Jones; Kathleen Sullivan; A Wesley Burks; Mary Ellen Conley; Charlotte Cunningham-Rundles; Hans D Ochs
Journal:  Medicine (Baltimore)       Date:  2006-07       Impact factor: 1.889

7.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

Authors:  D Vetrie; I Vorechovský; P Sideras; J Holland; A Davies; F Flinter; L Hammarström; C Kinnon; R Levinsky; M Bobrow
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

Review 8.  Enteroviruses in X-Linked Agammaglobulinemia: Update on Epidemiology and Therapy.

Authors:  David Bearden; Marc Collett; P Lan Quan; Beatriz T Costa-Carvalho; Kathleen E Sullivan
Journal:  J Allergy Clin Immunol Pract       Date:  2016-02-13

9.  Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study.

Authors:  Alessandro Plebani; Annarosa Soresina; Roberto Rondelli; Giorgio M Amato; Chiara Azzari; Fabio Cardinale; Gianantonio Cazzola; Rita Consolini; Domenico De Mattia; Grazia Dell'Erba; Marzia Duse; Maurilia Fiorini; Silvana Martino; Baldassarre Martire; Massimo Masi; Virginia Monafo; Viviana Moschese; Luigi D Notarangelo; Paola Orlandi; Pietro Panei; Andrea Pession; Maria C Pietrogrande; Claudio Pignata; Isabella Quinti; Vanda Ragno; Paolo Rossi; Antonella Sciotto; Achille Stabile
Journal:  Clin Immunol       Date:  2002-09       Impact factor: 3.969

10.  Gastrointestinal disorders next to respiratory infections as leading symptoms of X-linked agammaglobulinemia in children - 34-year experience of a single center.

Authors:  Malgorzata Pac; Ewa A Bernatowska; Jarosław Kierkuś; Józef P Ryżko; Joanna Cielecka-Kuszyk; Teresa Jackowska; Bożena Mikołuć
Journal:  Arch Med Sci       Date:  2016-06-01       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.